Asana (ASAN) Earnings Analysis
Asana (ASAN) next reports earnings on 2026-09-02, consensus EPS 0.09 USD. Last quarter (2026-05-28) it beat with EPS 0.1 USD vs 0.08 USD est (+25%). It has beaten estimates in 7/8 recent quarters (88%). Trailing P/E -9.96.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ASAN next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | 0.09 USD |
| Revenue estimate | 0.21B |
ASAN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-28 | 0.1 USD | 0.08 USD | +25% | Beat |
| 2026-03-02 | 0.08 USD | 0.07 USD | +14.3% | Beat |
| 2025-12-02 | 0.07 USD | 0.062 USD | +12.9% | Beat |
| 2025-09-03 | 0.06 USD | 0.05 USD | +20% | Beat |
| 2025-06-03 | 0.05 USD | 0.02573 USD | +94.3% | Beat |
| 2025-03-10 | -0.22 USD | -0.01 USD | -2100% | Miss |
| 2024-12-05 | -0.02 USD | -0.07 USD | +71.4% | Beat |
| 2024-09-03 | -0.05 USD | -0.08 USD | +37.5% | Beat |
Beat rate: 7/8 (88%) over reported quarters with consensus data.
ASAN valuation and analyst view
| Trailing P/E | -9.96 |
|---|---|
| Trailing EPS | -0.68613 USD |
| Price / book | 11.96 |
| Dividend yield | 0.00% |
| Market cap | 1.61B |
| Analyst consensus | Hold (8 buy / 9 hold / 2 sell) |
| Avg price target | 8 USD |
Related research pages
Frequently asked questions
When is Asana (ASAN)'s next earnings date?
Asana is next scheduled to report on 2026-09-02, with a consensus EPS estimate of 0.09 USD and revenue estimate of 0.21B.
Did ASAN beat earnings last quarter?
In its 2026-05-28 report, ASAN posted EPS of 0.1 USD versus a 0.08 USD estimate — a beat of 25%.
What is ASAN's earnings track record?
Over the last 8 reported quarters with consensus data, ASAN beat estimates 7 times (88%).
What is ASAN's current P/E ratio and EPS?
ASAN trades at a trailing P/E of -9.96 on trailing EPS of -0.6861280462202516 USD.
What do analysts rate ASAN?
Analyst consensus is "Hold" across 19 ratings (0 strong buy, 8 buy, 9 hold, 2 sell, 0 strong sell). Average 12-month price target: 8 USD.